Oup Management Co., LLC Landos Biopharma, Inc. Transaction History

Oup Management Co., LLC

  • $44.5 Million
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022
SELL
$0.67 - $1.26 $251,314 - $472,622
-375,097 Reduced 23.26%
1,237,667 $804,000
Q2 2022

Jul 19, 2022
SELL
$0.6 - $1.5 $128,828 - $322,071
-214,714 Reduced 11.75%
1,612,764 $1.17 Million
Q4 2021

Feb 03, 2022
BUY
$4.7 - $15.0 $8.59 Million - $27.4 Million
1,827,478 New
1,827,478 $8.77 Million

About Landos Biopharma, Inc.

LABP Quotes by TradingView
  • Ticker LABP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,254,900
  • Description
  • Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...
More about LABP
Track This Portfolio

Track Oup Management Co., LLC Portfolio

Follow Oup Management Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oup Management Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oup Management Co., LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email